Jobs and People
30 September 2002 00:00 [Source: ICB Americas]
Richard G. Babbitt
Richard G. Babbitt has been elected chairman of the board of
directors of Lipid Sciences Inc. Mr. Babbitt has an understanding
of the business issues an emerging company faces, as well as
experience in successfully commercializing medical products.
David Briscoe
David Briscoe has been appointed vice president of business
development and to the board of directors of GenOdys-see SA. Mr.
Briscoe has more than 27 years of experience in the pharmaceutical
and biotechnology industries.
Angela Cackovich
Angela Cackovich has been appointed market manager for additives
in Europe of Rohm and Haas Company. Ms. Cackovich joins the company
from Dow Corning Europe.
Steve Cullen
Steve Cullen has been appointed business development manager for
performance chemicals and intermediates business organization of
Eastman Chemical Com-pany. Mr. Cullen will focus om pharmaceutical
and custom synthesis development opportunities.
Mark G. Currie
Mark G. Currie has been appointed vice president of research and
development of Microbia Inc. Mr. Currie has more than 12 years of
pharmaceutical research experience.
Carol Eicher
Carol Eicher has been named vice president and general manager
of the Americas and Europe for the printed wiring board division of
Shipley Company LLC. Ms. Eicher joined the division in 2001.
Art Esposito
Art Esposito, marketing director of the performance products
group of Church and Dwight Co. Inc., has been elected second vice
chairperson of the Chemis-try Council of New Jersey.
Allan Fowler
Allan Fowler, site director of Dow Chemical Company, has been
elected treasurer of vice chairperson of the Chemistry Council of
New Jersey.
Jean-Marc Giry
Jean-Marc Giry has been appointed vice president of strategic
planning and to the board of directors of Gen-Odyssee SA. Mr. Giry
has more than 20 years of marketing and business development
experience.
David Goodkin
David Goodkin has joined Icos Corp. as vice president of
development and chief medical officer. Dr. Goodkin has more than 10
years of experience in drug development.
John Grate
John Grate has been appointed vice president of research and
development and chief technology officer of Codexis Inc. Mr. Grate
has worked with the company as a member of its industrial advisory
board since February 2002.
Hans Hickler
Hans Hickler, group chief information officer of Neptune Orient
Lines (NOL), has been named CEO of APL Logistics, a subsidiary of
NOL.
Kim David Lamon
Kim David Lamon has been elected to the board of directors of
ICN Pharmaceuti-cals Inc. Dr. Lamon has extensive corporate and
clinical experience in the pharmaceutical and biotechnology
industries.
John E. Lucas
John E. Lucas has joined RxKenetix Inc. as president and CEO.
Mr. Lucas brings extensive pharmaceutical and biotechnology
experience to the company.
Jean Maral
Jean Maral has been appointed to the board of directors of
GenOdyssee SA. He has more than 20 years of experience in the
development of therapeutic protein variants. Dr. Maral joined the
company in 2001.
Leonard J. Martocci
Leonard J. Martocci has been promoted to director of North
American sales, microelectronic materials of Mallinck-rodt Baker
Inc. He will spearhead and manage the efforts of the
microelectronic sales team. Mr. Martocci has been with the company
since 1979.
Maria Matilla
Maria Matilla has become product manager for architectural
binders of Rohm and Haas Company. Ms. Matilla joined the company in
1998.
Margie Nemcik-Cruz
Margie Nemcik-Cruz has been appointed vice president of
regulatory affairs of Amarin Pharmaceuticals Inc., the USdrug
development and marketing subsi-diary of Amarin Corp. PLC. Ms.
Nem-cik-Cruz has a track record of progressing innovative new
pharmaceutical pro- ducts through the regulatory processes.
Denise O'Leary
Denise O'Leary has been appointed to the board of directors of
Chiron Corp. She is a private venture capital investor. Ms. O'Leary
serves on the boards of Medtronics Inc., America West Holdings
Corp. and Del Monte Foods Company.
Philippe Remes
Philippe Remes has been appointed vice president of investor
relations and to the board of the board of directors of Gen-Odyssee
SA. Dr. Remes has more than 20 years of experience in the
biotechnology and pharmaceutical industries.
Joe Saco
Joe Saco, US manufacturing manager of Infineum USA LP has been
elected first vice chairperson of the Chemistry Council of New
Jersey.
John Schroeder
John Schroeder, president of Hydro-Globe LLC, has been elected
chairman of the Chemistry Council of New Jersey.
Avery Spunt
Avery Spunt has joined the National Association of Boards of
Pharmacy as competency assessment director. Mr. Spunt brings 30
years of experience at the University of Illinois at Chicago
College of Pharmacy.
James R. Weiss
James R. Weiss has been named infor-mation technology and
applications database director of the National Associ-ation of
Boards of Pharmacy. Mr. Weiss has more than 20 years of experience
in management and consulting.
ICIS Copyright © Reed Business Information 2009
< previous article(VIDEO - ICIS news Asia Lunchtime Bulletin 30 October 2009)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial
to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free
trial to ICIS Chemical Business.
Links posted in this story: